<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>肺癌前沿 | wechat-feeds</title><link>http://MzAwMzIwODEwNQ.favicon.privacyhide.com/favicon.ico</link><description>传递最新肺癌信息</description><managingEditor> (hellodword)</managingEditor><pubDate>Sun, 14 Feb 2021 11:36:39 +0800</pubDate><image><url>http://MzAwMzIwODEwNQ.favicon.privacyhide.com/favicon.ico</url><title>肺癌前沿 | wechat-feeds</title><link>http://MzAwMzIwODEwNQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>CheckMate 017/057的五年生存结果：Nivolumab在二线非小细胞肺癌治疗中优于多西他赛</title><link>https://mp.weixin.qq.com/s/EXCKX9IWemox2tWNhDm2TA</link><description></description><content:encoded><![CDATA[CheckMate 017/057的五年生存结果：Nivolumab在二线非小细胞肺癌治疗中优于多西他赛]]></content:encoded><pubDate>Sun, 14 Feb 2021 08:18:01 +0800</pubDate></item><item><title>[JCOG0804]：2cm以下磨砂玻璃成分为主肺结节楔形或肺段切除范围已足够</title><link>https://mp.weixin.qq.com/s/6cmy9IfAkPV1JpNc-ntisQ</link><description></description><content:encoded><![CDATA[[JCOG0804]：2cm以下磨砂玻璃成分为主肺结节楔形或肺段切除范围已足够]]></content:encoded><pubDate>Sat, 16 Jan 2021 17:58:50 +0800</pubDate></item><item><title>[JTCVS 2021] 肺腺癌侵袭性三维影像纹理量化模型的构建</title><link>https://mp.weixin.qq.com/s/0GP1aIgSMU37-OxwtWgT_g</link><description></description><content:encoded><![CDATA[[JTCVS 2021] 肺腺癌侵袭性三维影像纹理量化模型的构建]]></content:encoded><pubDate>Sat, 02 Jan 2021 17:55:06 +0800</pubDate></item><item><title>【CA】实体瘤新辅助治疗后重分期的现状与未来</title><link>https://mp.weixin.qq.com/s/Wf3IGKV_RpHETXx9R2k1uw</link><description></description><content:encoded><![CDATA[【CA】实体瘤新辅助治疗后重分期的现状与未来]]></content:encoded><pubDate>Mon, 07 Dec 2020 20:11:09 +0800</pubDate></item><item><title>广东省医学会肺部肿瘤学分会第二届年会</title><link>https://mp.weixin.qq.com/s/RKyiwcOArI4bg0E34ve_pQ</link><description></description><content:encoded><![CDATA[广东省医学会肺部肿瘤学分会第二届年会]]></content:encoded><pubDate>Thu, 03 Dec 2020 15:41:17 +0800</pubDate></item><item><title>EGFR突变非小细胞肺癌脑膜转移:奥希替尼的应用及基于脑脊液biomarker的探索</title><link>https://mp.weixin.qq.com/s/ADRecBimI-y8lnjTbKowFQ</link><description></description><content:encoded><![CDATA[EGFR突变非小细胞肺癌脑膜转移:奥希替尼的应用及基于脑脊液biomarker的探索]]></content:encoded><pubDate>Mon, 16 Nov 2020 20:50:21 +0800</pubDate></item><item><title>The Sentinel: SITC 2020 Scientific Highlights</title><link>https://mp.weixin.qq.com/s/iPYQfIvDZSrzWFiF0brKUQ</link><description></description><content:encoded><![CDATA[The Sentinel: SITC 2020 Scientific Highlights]]></content:encoded><pubDate>Fri, 13 Nov 2020 18:25:25 +0800</pubDate></item><item><title>[JTO]肺癌手术残留病灶（R）分级-定义和改良</title><link>https://mp.weixin.qq.com/s/3BroTl2Cl7nSeCiV0l8yXQ</link><description></description><content:encoded><![CDATA[[JTO]肺癌手术残留病灶（R）分级-定义和改良]]></content:encoded><pubDate>Tue, 27 Oct 2020 23:11:30 +0800</pubDate></item><item><title>肺静脉根部肺结节重建定位精确性切除</title><link>https://mp.weixin.qq.com/s/RmHCMZokoh2to1o-a_g9lA</link><description></description><content:encoded><![CDATA[肺静脉根部肺结节重建定位精确性切除]]></content:encoded><pubDate>Sat, 24 Oct 2020 00:08:26 +0800</pubDate></item><item><title>灼热射线点亮转移性肿瘤“暮光之城”</title><link>https://mp.weixin.qq.com/s/FJhbSaOhJiEzpks7oZfUyg</link><description></description><content:encoded><![CDATA[灼热射线点亮转移性肿瘤“暮光之城”]]></content:encoded><pubDate>Fri, 23 Oct 2020 17:42:32 +0800</pubDate></item></channel></rss>